These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15690231)

  • 21. Effect of Chronic Domperidone Use on QT Interval: A Large Single Center Study.
    Field J; Wasilewski M; Bhuta R; Malik Z; Cooper J; Parkman HP; Schey R
    J Clin Gastroenterol; 2019 Oct; 53(9):648-652. PubMed ID: 30720577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-induced prolongation of the QT interval: what's the point?
    White PF; Abrao J
    Anesthesiology; 2006 Feb; 104(2):386-7. PubMed ID: 16436877
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy of domperidone in infants and children with gastroesophageal reflux.
    Bines JE; Quinlan JE; Treves S; Kleinman RE; Winter HS
    J Pediatr Gastroenterol Nutr; 1992 May; 14(4):400-5. PubMed ID: 1517943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Domperidone: ventricular arrhythmia and sudden death (continued).
    Prescrire Int; 2012 Jul; 21(129):183. PubMed ID: 22852288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of domperidone on QTc interval in infants.
    Vieira MC; Miyague NI; Van Steen K; Salvatore S; Vandenplas Y
    Acta Paediatr; 2012 May; 101(5):494-6. PubMed ID: 22226330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Ondansetron on QT Interval in Patients Cared for in the PICU.
    Trivedi S; Schiltz B; Kanipakam R; Bos JM; Ackerman MJ; Ouellette Y
    Pediatr Crit Care Med; 2016 Jul; 17(7):e317-23. PubMed ID: 27387786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Domperidone: limited benefits with significant risk for sudden cardiac death.
    Hondeghem LM
    J Cardiovasc Pharmacol; 2013 Mar; 61(3):218-25. PubMed ID: 23188128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prokinetics in childhood].
    Gottrand F
    Arch Pediatr; 2010 Jun; 17(6):737-8. PubMed ID: 20654867
    [No Abstract]   [Full Text] [Related]  

  • 29. Survey of the use of domperidone and the association with QTc prolongation in general practice.
    Ioannou A; Jain A; Kassianos G; Missouris C
    Postgrad Med J; 2016 Jul; 92(1089):390-2. PubMed ID: 26802127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Domperidone, a new dopamine antagonist.
    Champion MC; Hartnett M; Yen M
    CMAJ; 1986 Sep; 135(5):457-61. PubMed ID: 3527396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of domperidone on the QTc interval in premature infants.
    Günlemez A; Babaoğlu A; Arisoy AE; Türker G; Gökalp AS
    J Perinatol; 2010 Jan; 30(1):50-3. PubMed ID: 19626027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of cisapride on QT interval in children].
    Tamariz-Martel Moreno A; Baño Rodrigo A; Sánchez Bayle M; Montero Luis C; Acuña Quirós MD; Cano Fernández J
    Rev Esp Cardiol; 2004 Jan; 57(1):89-93. PubMed ID: 14746724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous ECG monitoring of children with cancer receiving domperidone.
    Ratcliffe JM; Nobbs J; Campbell RW; Hunter AS; Pritchard-Jones K; Craft AW
    Pediatr Hematol Oncol; 1986; 3(4):343-6. PubMed ID: 3153247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Domperidone disaster: need for a single formulation?
    Sanklecha M; Charde V
    Indian J Pediatr; 2013 Jul; 80(7):615. PubMed ID: 23152162
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pharmacologic and clinical differentiation of prokinetic drugs].
    May B; Greving I
    Leber Magen Darm; 1996 Jul; 26(4):193-8. PubMed ID: 8965601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Domperidone, metoclopramide, and placebo. All give symptomatic improvement in gastroesophageal reflux.
    Maddern GJ; Kiroff GK; Leppard PI; Jamieson GG
    J Clin Gastroenterol; 1986 Apr; 8(2):135-40. PubMed ID: 3745846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noncardiac drugs and QTc interval prolongation: an often unrecognized risk factor for adverse cardiovascular outcomes.
    Sander GE; Guillory GS; Giles TD
    Am J Geriatr Cardiol; 2002; 11(3):197-202. PubMed ID: 11986537
    [No Abstract]   [Full Text] [Related]  

  • 38. [Domperidone and the risk of sudden cardiac death].
    van Roeden SE; Belle-van Meerkerk G; van Tuyl SA; van de Ree MA; Muller AF
    Ned Tijdschr Geneeskd; 2013; 157(45):A6770. PubMed ID: 24191928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis.
    Soykan I; Sarosiek I; McCallum RW
    Am J Gastroenterol; 1997 Jun; 92(6):976-80. PubMed ID: 9177513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prokinetics prescribing in paediatrics: evidence on cisapride, domperidone, and metoclopramide.
    Mt-Isa S; Tomlin S; Sutcliffe A; Underwood M; Williamson P; Croft NM; Ashby D
    J Pediatr Gastroenterol Nutr; 2015 Apr; 60(4):508-14. PubMed ID: 25825854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.